DeLia J E, Emery M G, Taylor R H, Scott J R
Clin Pharmacol Ther. 1982 Jul;32(1):76-80. doi: 10.1038/clpt.1982.129.
Reports on the efficacy of flurbiprofen for dysmenorrhea conflict. We gave 59 dysmenorrheic patients flurbiprofen (50 mg), aspirin (650 mg), or placebo. Paired drug comparisons showed that patients preferred flurbiprofen and that it was more effective in relief of pain, in allowing patients to pursue normal daily function, and in reducing the need for additional analgesics. Except in patient preference, aspirin was only marginally superior to placebo, There was an increase in minor side effects in the flurbiprofen group, but our results indicate therapeutic utility for flurbiprofen in dysmenorrhea.
关于氟比洛芬治疗痛经疗效的报告存在冲突。我们给59名痛经患者服用氟比洛芬(50毫克)、阿司匹林(650毫克)或安慰剂。成对药物比较显示,患者更喜欢氟比洛芬,且它在缓解疼痛、使患者能够进行正常日常活动以及减少额外镇痛药需求方面更有效。除了在患者偏好方面,阿司匹林仅略优于安慰剂。氟比洛芬组轻微副作用有所增加,但我们的结果表明氟比洛芬在痛经治疗中有实用价值。